top of page
Avenra Therapeutics (not Averna)
Structure-of-Xanthine-Oxidase-3NRZ-obtained-from-RCSB-PDB.png
Avenra focuses on prophylactic phytotherapy — intervening before disease manifests by preserving vitality, enhancing adaptive responses (homeostasis), and supporting the body's innate repair mechanisms. This contrasts with purely reactive treatment models.

Avenra prioritizes ethical, traceable sourcing, sustainable and controlled cultivation, and eco-friendly processing to maintain the integrity of botanical actives from farm to finished product.

OUR FOCUS
Epidemiological evidence and prior clinical studies suggest that preventive therapy including antioxidants, flavonoids, and polyphenols correlates with better cognitive health.  However, these have not yet been translated into an FDA-approved therapeutic.

Avenra, through our AV‑01 platform, aims to fill this gap.  AV-01 provides a standardized, high-potency, nutrient-dense therapy as an FDA-approved drug for vascular cognitive impairment prevention. 

We're combining the safety of a food with the rigorous quality, safety, and proven clinical efficacy requirements of a pharmaceutical product.
Scientist Using Microscope
bottom of page